Elevance's forecast cut magnifies medical cost woes for US health insurers
The company kicked off quarterly earnings for U.S. health insurers, a spot usually taken by industry bellwether UnitedHealth Group (UNH.N), opens new tab.
Health insurers have come under pressure from tougher regulations and rising costs. Government-focused plans are under strain due to funding pressures, while Medicaid costs are rising without adequate state rate adjustments.
UnitedHealth, which is expected to report earnings on July 29, already cut its annual profit forecast in May, citing higher demand for medical care in government-backed plans.
Forecast cuts from peers Centene (CNC.N), opens new tab and Molina Healthcare (MOH.N), opens new tab followed soon due to a similar trend from members in state and federally-funded Medicaid plans as well as in so-called Obamacare.
Elevance on Wednesday said it sees annual adjusted profit of about $30 per share, compared with $34.15 to $34.85 per share it previously expected.
J.P.Morgan analyst Lisa Gill said the forecast cut was largely in the range that investors were expecting going into the quarter.
Shares of Elevance were down 1% in premarket trading, partially recovering from an initial slump of as much as 9%.
Elevance forecast full-year medical loss ratio, a closely watched metric which tracks medical costs, to be about 90%, reflecting the ongoing industry-wide trend of higher costs on Medicaid and Obamacare plans.
For the quarter, Elevance reported a medical loss ratio, the percentage of premiums spent on medical care, of 88.9% compared to analysts' estimates of 88.70%.
Elevance banks more on commercial and Medicaid health plans, which cover medical expenses for people with low income with about 19.1% of its members coming from Medicaid as of June 30.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
29 minutes ago
- Daily Mail
Trump demands UK pharmaceutical giants to lower drug costs sparking fears NHS could pay the price if they refuse
Donald Trump has demanded UK pharmaceutical giants lower prices for America and suggested charging others to make up the difference. He said if they didn't, the US would deploy 'every tool in our arsenal' to protect families from 'continued abusive drug prices', sparking fears the NHS will end up paying more. Mr Trump suggested he would use tariffs to push through higher prices if countries resisted. In May Mr Trump signed an executive order demanding drugmakers cut US medicine prices to match those abroad. Yesterday in a letter to 17 pharma companies he said he expected them to deliver on measures by September 29. He asked them to apply 'most favoured nation' pricing to Medicaid, the US health programme for people on low incomes. Mr Trump also asked drugmakers to offer new medicines at the same price in the US as in other developed countries. He said: 'Our citizens pay massively higher prices than other nations pay for the same exact pill... subsidizing socialism aboard [abroad].' British pharma companies AstraZeneca and GSK were among the recipients. Others included Eli Lilly, Johnson & Johnson, Pfizer and Sanofi. The UK Government said it would 'continue to work closely with the US to get the best deal for our pharma industry and deliver mutual benefits for both our countries'.
Reuters
29 minutes ago
- Reuters
Trump says Brazil's Lula can call him anytime
WASHINGTON/BRASILIA, Aug 1 (Reuters) - U.S. President Donald Trump said on Friday that Brazilian President Luiz Inacio Lula da Silva can call him anytime to discuss tariffs and other friction between the countries. "He can talk to me anytime he wants," Trump said of Lula, speaking to reporters at the White House. He added he was fond of the Brazilian people but "the people running Brazil did the wrong thing." Later, speaking with reporters in Brasilia, Brazil Finance Minister Fernando Haddad called Trump's remarks "great," saying he is sure Lula feels the same, and would be willing to receive a call from the U.S. president. In a post on his X account, Lula said Brazil has always been open to dialogue, although he did not mention Trump nor his earlier remarks. Trump slapped a 50% tariff on Brazil, with many exemptions, starting next week to fight what he has called a "witch hunt" against former President Jair Bolsonaro, who is on trial on charges of plotting a coup following his election loss in 2022. The U.S. also announced sanctions on a Brazilian Supreme Court justice who has been overseeing Bolsonaro's trial. Lula has rejected both the sanctions and the tariffs, calling them "unjustifiable" and an "unacceptable" interference in Brazil's justice system. Haddad said his planned virtual meeting with U.S. Treasury Secretary Scott Bessent next week will pave the way for an eventual meeting between Lula and Trump, but noted such a move would require preparation. Earlier this week, Haddad said Brazil needed assurance Lula would not face the same treatment as Ukraine's Volodymyr Zelenskiy, who came under fire from Trump and Vice President JD Vance during a heated exchange at the White House earlier this year.
Reuters
29 minutes ago
- Reuters
Commanders cleared to build new stadium in D.C.
August 1 - After nearly three decades of playing in Maryland, the Washington Commanders have the green light to build a new $3.7 billion stadium in D.C. that should bring them back to the nation's capital by 2030. The D.C. Council voted 9-3 on Friday to ratify the deal between the city and the NFL team. The site of the new 174-acre complex will be the same as RFK Stadium, which remains in place even though the team moved out prior to the 1997 season. "This is a historic moment," Commanders managing partner Josh Harris said in a statement. "This project is about more than delivering a world-class stadium worthy of our players, fans and the region. It's about revitalizing a critical part of our city, creating thousands of jobs and unlocking long-term economic benefits for the District. We look forward to working with our fans, residents, community leaders and elected officials to deliver on this vision." The franchise enjoyed its finest years at the RFK site, which opened in 1961 as District of Columbia Stadium. During the team's 36 seasons at RFK, it won Super Bowls VII, XXII and XXVI while appearing in two more and earning eight other playoff appearances. Since former owner Dan Snyder moved the team to now-Northwest Stadium in Landover, Md., in 1997, Washington has amassed just seven playoff appearances in 28 years. Last season's run to the NFC title game was the Commanders' first push past the divisional round since 1991. Snyder's decision to sell his team in 2022 - a move encouraged by the NFL - helped pave the way for the franchise's return to D.C. In addition, Harris indicated his willingness to foot more of the bill than most owners. According to details of the deal, the Commanders are expected to handle $2.7 billion of the stadium's cost along with any overruns. The District of Columbia will pay $1 billion, but much of that is expected to be recouped over the long haul in taxes and other revenue streams. --Field Level Media
